Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: January 29, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2026
Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Outcomes after SRS and ipilimumab plus nivolumab for melanoma brain metastases following prior immune checkpoint inhibitor or targeted therapy.
Journal: The oncologist
Published: November 07, 2025
ASO Visual Abstract: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.
Journal: Annals of surgical oncology
Published: October 08, 2025
Topical Resiquimod Elicits Systemic Protection and Improves Anti-PD-1 Therapy in Melanoma via Priming of CD8+ T Cells.
Journal: Cancer immunology research
Published: August 11, 2025
Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.
Journal: Annals of surgical oncology
Published: July 24, 2025
Corrigendum to Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.
Journal: The Journal of clinical investigation
Published: July 15, 2025
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 12, 2025
Mohs-facilitated excision: A case series of a multidisciplinary approach to reduce local recurrence of advanced keratinocyte carcinomas.
Journal: Journal of the American Academy of Dermatology
Published: April 17, 2025
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade.
Journal: Cancer cell
Published: January 19, 2025
Last Updated: 09/26/2026